Linked Life Data

18467725

Source:http://linkedlifedata.com/resource/pubmed/id/18467725

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2008-5-9
pubmed:abstractText
This study was undertaken to examine five possible prognostic factors in patients with recurrent stage II and III colon cancer: time from randomization on an adjuvant therapy clinical trial to tumor recurrence (< 1 year, 1 to 2 years, 2 to 3 years, 3 to 4 years, > 4 years), initial stage (II v III), initial adjuvant treatment (fluorouracil [FU]-based v surgery alone), the era in which the patient entered an adjuvant therapy clinical trial (1978 to 1985, 1986 to 1992, 1993 to 1999), and patient age at recurrence.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2336-41
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
pubmed:affiliation
National Surgical Adjuvant Breast and Bowel Project Operations Office, Pittsburgh, PA 15212-5234, USA. michael.oconnell@nsabp.org
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural